Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out


March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info:
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect TMAU

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed
Follow MeBOResearch on Twitter

Blog Archive

MEBO Metabolic Malodor Survey (international) for Dr Hazen click here
click to Read more/less

survey for ANYONE who identifies with METABOLIC MALODOR

begun : Oct20
end : no ending for now

Regular readers will know that Dr Stan Hazen et al at Cleveland Clinic are developing a TMA-blocker pill, as they proposed in a 2011 paper that TMAO is a factor in CVD. Recently Dr Hazen and colleagues contacted MEBO as they have always thought they could also help with TMAU. This survey is to give them an idea of the 'state of the community'. It is a "version 1". They may not even look (though they have access permission), but it could be useful to give them an overview of the community

MEBO had a zoom call with Dr Hazen and his team in October. Another zoom call is planned when they have time

This is a GOOGLE FORMS survey

short url for survey :

current participants : 113 (update 18dec20)

Tuesday, January 6, 2009

ISBOR bi-annual breath malodor conference in Dortmund April 26-30

Note : The secretary said the public can attend this, but it is quite costly to enter the conference hall. See their website for details (and perhaps email to confirm)

The International Society for Breath Odor Research (ISBOR) is holding their 8th bi-annual conference in Dortmund on April 26-30. This year it will be a joint conference with the International Association for Breath Research (IABR).

ISBOR focuses on oral malodor, whereas IABR focuses on all aspects of 'breath analysis'.

It is of great interest to both bloodborne body odor and halitosis, as well as 'local' halitosis, because they focus their research on 'breathometers' that detect the compounds in breath. Perhaps someday there will be body odor (& halitosis) conferences too (with the emphasis on metabolic body odors)

The International Society of Breath Odor Research was created in Leuven Belgium in 1995 at the occasion of the second International Workshop on Oral Malodor. Indeed, inspired by the first workshop organized in Israel in 1993 by Mel Rosenberg, a second conference was organized by Daniel van Steenberghe and Mel Rosenberg. It gathered 140 scientists and clinicians from 16 countries representing everything from ENT to dentistry and from gastroenterology to periodontology. Since 1995, seven ISBOR conferences have taken place throughout the world including Herzliya 1993, Leuven 1995, Vancouver 1997, Los Angeles 1999, Tokyo 2001, London 2004, and Chicago 2007. The eighth ISBOR international conference will be in Dortmund, Germany in April 2009.

The aim of ISBOR, as defined in the constitution, seeks to "promote research and dissemination of research findings in all aspects related to breath odor." Until two decades ago, the knowledge of this very relevant social and health issue was limited, and its teaching anecdotal, ISBOR has been able to raise the awareness of and interest in the implications of breath odor for general health care. ISBOR represents a unique multidisciplinary gathering of people convinced that cross-fertilization is beneficial for the advancement of science and patient care.


Post a Comment